Author: Anna Bersano
Chair ESO Education Committee
Moyamoya Day 13 December 2024
The event aimed to increase awareness, share the latest research findings, and enhance clinical practices in managing moyamoya angiopathy. It emphasized multidisciplinary collaboration to improve outcomes for patients affected by this rare cerebrovascular disorder.
The day featured a comprehensive agenda covering clinical, neuroradiological, surgical, and psychological aspects of moyamoya angiopathy. Experts from Italy and Europe shared their insights through presentations and discussions.
The event began with institutional greetings by Marta Marsilio, and Giuseppe Lauria Pinter who emphasized the importance of research and multidisciplinary collaboration.
The first session focused on clinical and pathophysiological aspects. Nicola Rifino presented an overview of clinical aspects and the Italian series. Elisa Ciceri discussed neuroradiological features, followed by Patrizia De Marco, who delved into the genetic landscape and pathophysiology of the disease. Antonella Potenza presented the latest findings on biological disease markers. The session concluded with insights from international experts Anne Hege Aamodt and Dominique Hervé, who shared their clinical experiences in Norway, Germany, and France.
In the afternoon, the programme shifted to neurosurgical perspectives. Peter Vajkoczy outlined the German experience, focusing on surgical outcomes in moyamoya patients. Markus K.H. Wiedmann shared insights from the Norwegian cohort, while Francesco Acerbi presented findings from the Milan cohort, highlighting different neurosurgical approaches. Marco Pavanello provided an update on pediatric surgical outcomes from Genoa.
The final session explored future perspectives. Anna Bersano discussed recent developments in moyamoya guidelines and their implications for diagnosis and management. Dominique Hervé provided updates on the European Registry, and Carolina De Toma and Giulia Marinoni addressed cognitive and psychological aspects. The event concluded with an engaging discussion and closing remarks.
The event brought together a diverse audience, including neurologists, neurosurgeons, neuroradiologists, biologists, and other healthcare professionals. It fostered collaboration and knowledge exchange, promoting advancements in the diagnosis and treatment of moyamoya angiopathy.
Supported by the Italian Ministry of Health through the project “Empowering the Pathophysiology and Prognosis of Moyamoya Arteriopathy,” the event underlined the importance of continued research and the development of unified clinical guidelines.
—
ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2025 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.
